(Q36585213)

15 August 2017

Design, synthesis and crystallization of a novel glucagon analog as a therapeutic agent (English)

1 reference

15 August 2017

1 reference

Pengyun Li

1

1 reference

15 August 2017

Tanya Rogers

2

1 reference

15 August 2017

David Smiley

3

1 reference

15 August 2017

Richard D DiMarchi

4

1 reference

15 August 2017

Faming Zhang

5

1 reference

15 August 2017

15 June 2007

1 reference

Acta Crystallographica Section F: Structural Biology Communications

15 August 2017

1 reference

15 August 2017

63

1 reference

15 August 2017

Pt 7

1 reference

15 August 2017

599-601

1 reference

Gut peptides in the regulation of food intake and energy homeostasis

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

A teleological view of obesity, diabetes and hypertension.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Glucagon and glucagon-like peptide receptors as drug targets.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Overweight and obesity: prevalence, consequences, and causes of a growing public health problem

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Glucagon: the effects of its excess and deficiency on insulin action.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Hyperglycemia in the critically ill patient

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Central pre-proglucagon derived peptides: opportunities for treatment of obesity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Solvent content of protein crystals

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2335127

Glucagon and insulin hypoglycaemia

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17620721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17620721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Exendin-4 and exendin-(9–39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7–36)NH2

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17620721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1107/S1744309107028655

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

17620721

1 reference